60
Participants
Start Date
February 6, 2017
Primary Completion Date
December 15, 2019
Study Completion Date
February 17, 2020
Tafenoquine
Tafenoquine tablet is supplied as film-coated tablet (100 mg, 150 mg, 200 mg and 300 mg) and fast-dispersing film coated tablet (50 mg).
Chloroquine
Subjects may receive chloroquine according to local/national treatment guidelines.
GSK Investigational Site, Hanoi
GSK Investigational Site, Ho Chi Minh City
GSK Investigational Site, Montería
GSK Investigational Site, Ho Chi Minh City
Lead Sponsor
Medicines for Malaria Venture
OTHER
GlaxoSmithKline
INDUSTRY